Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-25-000348
Filing Date
2025-05-15
Accepted
2025-05-15 12:31:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11232
2 mrns13g.htm EX-99.1 AGREEMENT 9720
  Complete submission text file 0000935836-25-000348.txt   22815
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Subject) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88269 | Film No.: 25950654
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 225 AVENUE I STE 205 REDONDO BEACH CA 90277
Business Address 225 AVENUE I STE 205 REDONDO BEACH CA 90277 9174461561
Beryl Capital Management LLC (Filed by) CIK: 0001719307 (see all company filings)

EIN.: 474641111 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A